Impact of Intravenous Ferric Carboxymaltose on Quality of Life in Patients with Iron Deficiency Anemia: A Prospective Observational Study
IV ferric carboxymaltose is a safe and effective therapy for IDA, offering rapid hematological recovery and improved quality of life. However, hypophosphatemia remains a concern at higher doses, warranting close monitoring and further investigation.
Authors
- Emin Gemcioğlu (ORCID: https://orcid.org/0000-0001-9751-8452)
- Rıfat Bozkuş (ORCID: https://orcid.org/0000-0003-1179-0653)
- Şeyma Sarışen (ORCID: https://orcid.org/0009-0006-9096-2714)
Institutions
- Memorial Ankara Hospital (TR)
Publication Details
- Journal
- International Journal of General Medicine
- Published
- 2025-12-01
- DOI
- https://doi.org/10.2147/ijgm.s559861
- Primary Topic
- Erythropoietin and Anemia Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00